HIV

The Pharmacy Times® human immunodeficiency virus (HIV) resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

What can we help you find?

Novel Dual CAR T Cell Immunotherapy Could Help Target HIV Reservoir

Although antiretroviral therapy is an important option for patients with HIV, the viral reservoir has been a major obstacle for researchers looking to effectively cure the disease.

Identification of Viral Reservoirs Could Lead to a Functional Cure for HIV

According to results from a recent study, a functional cure for HIV may lie in identifying the viral reservoirs in which HIV places copies of its viral genetic material into cell genomes.

Study: Beating HIV, COVID-19 May Depend on Modifying Vaccine Molecules

According to the study authors, with a higher antigen valency, antibodies have more sites to latch onto; however, including a higher antigen valency in a vaccine does not mean it will work better.

HIV and Immunotherapy: The Immune System Awakens

Antiretroviral therapy’s limitations lead to new efforts to treat the virus by neutralizing antibodies.

Sugar-Based Signature Can Identify Persistent HIV Reservoirs

Despite, antiretroviral therapy, HIV can hide in blood and tissue.

Multiple Sclerosis Drug May Block HIV Infection

Fingolimod (Gilenya), which is approved by the FDA to treat multiple sclerosis flare-ups, may also block HIV and reduce the latent reservoir.

Kidney Transplant Safe Between People With HIV

A new study found that it’s safe for patients with HIV to receive HIV-positive kidneys.

Turning the COVID-19 Conversation Into One on Overall Health

As patients return to their routines of returning to pharmacies and the inevitable discussions about COVID-19 begin, it may be a good time to discuss the range of tests that the CDC recommends.

Integrase Strand Transfer Inhibitors Associated With Weight Gain in Patients With HIV

Globally, dolutegravir is expected to be a part of treatment for approximately 15 million people living with HIV by 2021.

Antiretroviral Therapy, Anticoagulants in HIV-infected Patients for Stroke Prevention in Atrial Fibrillation

Significant morbidity and mortality are associated with an aging population due to cardiovascular disease, which is very common in HIV-infected persons.

FDA Approves Fostemsavir for HIV Treatment

Fostemsavir is indicated for adults with drug resistant HIV.

FDA Approves Dolutegravir for Infants, Children with HIV

Dolutegravir tablets are intended to treat pediatric patients at least 4 weeks old and at least 6 pounds who have never been treated for HIV or who have been treated, but not with an integrase strand transferase inhibitor class drug, according to the press release.

Medication adherence plays a vital role in the success, or failure, of patients with HIV/AIDS. This Pharmacy Times® specialty page serves as a hub for all clinical news that pharmacists need to know about HIV treatment and possible prevention. The coverage includes breaking news coverage of approvals from the US Food and Drug Administration, key takeaways from the latest novel therapies in clinical trials, and notifications of updates to clinical guidelines for the conditions. Additionally, this page provides suggestions for ways that pharmacists can collaborate with physicians to help overall continued care.